Alterity Therapeutics Ltd
ATHE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001131343
In the last 90 days, Alterity Therapeutics Ltd insiders filed 1 open-market purchase and 0 sales; 21 institutions reported holding it in 13F filings for Q2 2026, worth $2.12M in total; no superinvestor holds it.
Other share classesPRNAF
Q1 2023 vs. Q4 2022
How the institutions holding Alterity Therapeutics Ltd changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Of which not filed for Q1 2023 | Q1 2023 | Change |
|---|---|---|---|---|
| Holders | 13 | 1 | 7 | −5 |
| SharesConverted for a 1-for-10 split | 66.2K | 21.6 | 93.8K | +27.6K (+41.7%) |
| Value | $230.5K | $75 | $260.3K | +$29.9K (+13.0%) |
1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (1)
Institutions that held Alterity Therapeutics Ltd at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Twin Lakes Capital Management, LLC | 5,925 | $16.4K | 0.01% |
Sold out (6)
Institutions that held Alterity Therapeutics Ltd at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Millennium Management LLC | 96,838 | $34.0K |
| BNP Paribas Arbitrage, SA | 700 | $244 |
| The PNC Financial Services Group, Inc. | 400 | $140 |
| Coppell Advisory Solutions LLC | 149 | $52 |
| Coppell Advisory Solutions Corp. | 149 | $52 |
| FMR LLC | 1 | $0 |
Not filed for Q1 2023 yet (1)
Institutions that held Alterity Therapeutics Ltd at the end of Q4 2022 and haven't filed a 13F for Q1 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| CoreCap Advisors, LLC | 216 | $75 |